Filing Details

Accession Number:
0000891293-15-000059
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-20 17:39:39
Reporting Period:
2015-11-19
Filing Date:
2015-11-20
Accepted Time:
2015-11-20 17:39:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891293 Cti Biopharma Corp CTIC Pharmaceutical Preparations (2834) 911533912
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204260 A Louis Bianco 3101 Western Ave
Suite 600
Seattle WA 98121
Evp, Finance & Administration No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-11-19 800 $1.10 920,547 No 4 S Direct
Common Stock Disposition 2015-11-19 1,400 $1.11 919,147 No 4 S Direct
Common Stock Disposition 2015-11-19 3,800 $1.11 915,347 No 4 S Direct
Common Stock Disposition 2015-11-19 200 $1.12 915,147 No 4 S Direct
Common Stock Disposition 2015-11-19 1,000 $1.12 914,147 No 4 S Direct
Common Stock Disposition 2015-11-19 1,000 $1.13 913,147 No 4 S Direct
Common Stock Disposition 2015-11-19 1,200 $1.13 911,947 No 4 S Direct
Common Stock Disposition 2015-11-19 100 $1.14 911,847 No 4 S Direct
Common Stock Disposition 2015-11-19 806 $1.14 911,041 No 4 S Direct
Common Stock Disposition 2015-11-19 2,994 $1.15 908,047 No 4 S Direct
Common Stock Disposition 2015-11-19 500 $1.15 907,547 No 4 S Direct
Common Stock Disposition 2015-11-19 1,100 $1.16 906,447 No 4 S Direct
Common Stock Disposition 2015-11-19 100 $1.16 906,347 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 37 Indirect Trust for children
Footnotes
  1. The sale was effected pursuant to a Rule 10b5-1 trading plan.